Pelican Acquisition Corporation Ordinary Shares Total Liabilities
Pelican Acquisition Corporation Ordinary Shares total liabilities. Based on the latest financial reports, Pelican Acquisition Corporation Ordinary Shares (PELI) has total liabilities worth $583.17K USD as of January 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See working capital position of Pelican Acquisition Corporation Ordinary to evaluate short-term liquidity relative to the company's equity base.
Total Liabilities of Pelican Acquisition Corporation Ordinary Shares (2025–2026)
Total liabilities of Pelican Acquisition Corporation Ordinary Shares from 2025 to 2026. This chart illustrates how Pelican Acquisition Corporation Ordinary Shares's total liabilities have evolved over time, based on quarterly financial data.
Pelican Acquisition Corporation Ordinary Shares Competitors by Total Liabilities
The table below lists competitors of Pelican Acquisition Corporation Ordinary Shares ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
AIAI Holdings Corporation Class A Common Stock
NASDAQ:AIAI
|
USA | $317.93 Million |
|
Lang Inc
TW:6165
|
Taiwan | NT$1.61 Billion |
|
I-Berhad
KLSE:4251
|
Malaysia | RM614.71 Million |
|
After You Public Company Limited
BK:AU
|
Thailand | ฿490.45 Million |
|
Capstone Energy Plus, Inc. Common Stock
NASDAQ:CEPL
|
USA | $85.10 Million |
|
Immunoprecise Antibodies Ltd
NASDAQ:IPA
|
USA | $20.82 Million |
|
Investeringsselskabet Luxor A/S
CO:LUXOR-B
|
Denmark | Dkr587.75 Million |
|
Net Insight AB (publ)
ST:NETI-B
|
Sweden | Skr196.14 Million |
Liability Composition Analysis (2025–2026)
This chart breaks down Pelican Acquisition Corporation Ordinary Shares's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see PELI total assets.
Liquidity & Leverage Metrics
Pelican Acquisition Corporation Ordinary Shares Total Liabilities Ratios Explained
Pelican Acquisition Corporation Ordinary Shares total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.28 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.01 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.01 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Pelican Acquisition Corporation Ordinary Shares's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Pelican Acquisition Corporation Ordinary Shares (2025–2026)
The table below shows the annual total liabilities of Pelican Acquisition Corporation Ordinary Shares from 2025 to 2026.
| Year | Total Liabilities | Change |
|---|---|---|
| 2026-01-31 | $583.17K | +182.88% |
| 2025-01-31 | $206.15K | -- |
About Pelican Acquisition Corporation Ordinary Shares
Pelican Acquisition Corporation does not have significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities in technology industry. Pelican Acquisition Corporation was incorporated in 2024 and is based in New York, New York.